A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
A lucky road worker who scooped £1 million on a £5 lottery scratchcard has promised to go back to work - but this time without the overtime.
A 50-year-old man has been arrested after he was seen wearing a T-shirt in a pub that mocked the victims of the Hillsborough disaster.
Spots of rain reaching the region on Tuesday evening with some showers on Wednesday. High pressure building from Thursday